Inhibitory effect of Sarcophytol A on pancreatic carcinogenesis after initiation by N-nitrosobis(2-oxypropyl)amine in Syrian hamsters

Pancreas

Volumn 13, Issue 2, 1996, Pages 154-159

  Yokomatsu, Hideaki ^a   Hiura, Akihito ^a   Tsutsumi, Masahiro ^b   Satake, Katsusuke ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

N Nitrosobis(2 oxypropyl)amine; Pancreatic carcinogenesis; Postinitiation; Sarcophytol A

Indexed keywords

BIS(2 OXOPROPYL)NITROSAMINE; CYCLINE; SARCOPHYTOL A;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CARCINOGENESIS; CARCINOMA IN SITU; CONTROLLED STUDY; DIET SUPPLEMENTATION; FEMALE; GENE MUTATION; HYPERPLASIA; INVASIVE CARCINOMA; LABELING INDEX; NONHUMAN; ONCOGENE K RAS; ORAL DRUG ADMINISTRATION; PANCREAS DUCT; PANCREAS TUMOR; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; SYRIAN HAMSTER;

EID: 0029832012     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006676-199608000-00006     Document Type: Article

References (17)

1. Fujiki H, Suganuma M, Yoshikawa S, Takagi K, Kobayashi M. Sarcophytol A and B inhibit tumor promotion by teleocidin in two stage carcinogenesis in mouse skin. J Cancer Res Clin Oncol 1989;115:25-8.
2. Narisawa T, Takahashi M, Niwa M, Fujiki H. Inhibition of methyl-nitrosourea-induced large bowel cancer developing in rats by sarcophytol A, a product from a marine soft coral Sarcophyton glaucum. Cancer Res 1989;49:3287-9.
3. Fujiki H, Suganuma M, Suguri H, et al. New antitumor promoters: (-)epigarocatecin gallate and sarcophytol A and B. In: Kuroda K, Shenkel DH, Water MD, eds. Antimutagenesis and anticarcinogenesis mechanism II. New York: Plenum Press, 1989;205-12.
4. Yamauchi O, Omori M, Ninomiya M, et al. Inhibitory effect of sarcophytol A on development spontaneous hepatoma in mice. Jpn J Cancer Res 1991;82:1234-8.
5. Yokomatsu H, Satake K, Hiura A, Tsutsumi M, Suganuma M. Sarcophytol A: a new chemotherapeutic and chemopreventive agent for pancreatic cancer. Pancreas 1994;9:526-30.
6. Konishi Y, Mizumoto K, Kitazawa S, Tsujiuchi T, Tsutsumi M, Kawano T. Early ductal lesions of pancreatic carcinogenesis in animals and hamsters. Int J Pancreatol 1990;7: 83-9.
7. Tsutsumi M, Kondoh S, Noguchi O, et al. K-ras mutation in early ductal lesions induced in a rapid production model for pancreatic carcinomas in Syrian hamsters. Jpn J Cancer Res 1993;84:1101-5.
8. Tsutsumi M, Murakami Y, Kondoh S, et al. Comparison of k-ras oncogene activation in pancreatic duct carcinoma and cholangiocarcinomas induced in hamsters by N-nitrosobis(2-hydroxypropyl)amine. Jpn J Cancer Res 1993;84:856-960.
9. Wei H, Frenkel K. Suppression of tumor promoter-induced oxidative events and DNA damage in vivo by sarcophytol A: a possible mechanism of promotion. Cancer Res 1992;52: 2298-303.
10. Almoguera C, Shibata D, Forrester K, Marten J, Arnheim N, Perucho M. Most human carcinoma of the exocrine pancreas contain c-k-ras genes. Cell 1988;53:549-54.
11. Smith VTH, Boot AJM, Smits AMM, Fleureu K, Cornelesse DJ, Bos JL. K-ras codon 12 mutation occur very frequently on pancreatic adenocarcinoma. Nucleic Acid Res 1988;16: 775-8.
12. Grunewald K, Lyohs J, Frolich A, et al. High frequency of CK-ras codon 12 mutations in pancreatic adenocarcinoma. Int J Cancer 1989;43:1037-41.
13. Murayama M, Kishi K, Obata H, Nishimura S. Frequency and type of point mutation at the 12th codon of the c-(ki)-ras gene found in pancreatic cancers from Japanese patients. Jpn J Cancer Res 1989;80:622-6.
14. Ushijima T, Tsustumi M, Sakai S, et al. Ki-ras activation in pancreatic carcinoma of Syrian hamsters by N-nitrosobis(2-hydroxypropyl)amine. Jpn J Cancer Res 1991;82:965-8.
15. Cerny WL, Mangold KI, Scapelli DS. Activation of k-ras in transplantable pancreatic adenocarcinoma of Syrian golden hamsters. Carcinogenesis 1990;11:2075-9.
16. Fujii H, Egami H, Chaney W, Pour P, Felling J. Pancreatic adenocarcinoma induced in Syrian golden hamsters by N-nitrosobis(2-oxypropyl)amine contains c-ki-ras oncogenes with a point mutated codon 12. Mol Carcinogen 1990;3:296-301.
17. Scherer E, Zorgodrager F, von Kranen HJ, Woutersen RA. Activation of c-K-ras by point mutation in BOP-induced precancerous lesions and adenocarcinoma of Syrian golden hamsters. Int J Pancreatol 1993;14:91 (abstract).